skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Ten lessons learned from conducting an adherence intervention trial

Commentary

(3983) Views  (722) Full article downloads

Authors: Jeannie K Lee, Karen A Grace, Allen J Taylor

Published Date April 2009 Volume 2009:3 Pages 93 - 98
DOI: http://dx.doi.org/10.2147/PPA.S5394

Jeannie K Lee1, Karen A Grace3, Allen J Taylor3

1College of Pharmacy, University of Arizona, Tucson, AZ, USA; 2Department of Pharmacy, Walter Reed Army Medical Center, Washington DC, USA; 3Cardiology Division, Washington Hospital Center, Washington DC, USA

Abstract: Clinical practice research provides a unique opportunity to care for a diverse patient population in various health care system settings. Federal study of Adherence to Medications in the Elderly (FAME) was the first prospective observational and randomized controlled trial to implement effective strategies to enhance medication adherence and health outcomes in older patients using polypharmacy. Ten lessons learned from conducting this adherence intervention trial are described: (1) Link the trial to existing clinical work, (2) Begin with a thorough understanding of medication adherence, (3) Ensure that trial highlights individualized intervention, (4) Tailor inclusion criteria and study duration to target population, (5) Employ a range of outcomes linked to meaningful clinical effects, (6) Win the support of the multidisciplinary team and the administration, (7) Promote team work, (8) Consider the potential limitations, (9) Seize the grant opportunities, and (10) Share the findings.

Keywords: adherence, pharmacist, intervention, medication








Readers of this article also read:

Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Potential renovascular hypertension, space missions, and the role of magnesium
Critical appraisal of the role of glucosamine and chondroitin in the management of osteoarthritis of the knee
Ego mechanisms of defense are associated with patients’ preference of treatment modality independent of psychological distress in end-stage renal disease
Can a gentamicin-specific chart reduce neonatal medication errors?
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered
Dashboards in neonatology
Compliance, concordance, and patient-centered care
Everolimus-eluting stents: update on current clinical studies
Metabolic pathway and distribution of superparamagnetic iron oxide nanoparticles: in vivo study